Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Morris

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Reproductive Sciences (Thousand Oaks, Calif.)|August 20, 2020
Molecular Basis Supporting the Association of Talcum Powder Use with Increased Risk of Ovarian CancerNicole M Fletcher, Amy K Harper, Ira Memaj, et al.
Nucleic Acids Research|July 24, 2014
dREAM co-operates with insulator-binding proteins and regulates expression at divergently paired genesMichael Korenjak, Eunjeong Kwon, Robert T Morris, et al.
Journal of Ovarian Research|November 26, 2008
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaBLeigh A Solomon, Shadan Ali, Sanjeev Banerjee, et al.
American Journal of Obstetrics and Gynecology|December 27, 2008
A comparison of younger vs older women with vulvar cancer in the United StatesSanjeev Kumar, Jay P Shah, Christopher S Bryant, et al.
Plant Science : an International Journal of Experimental Plant Biology|March 23, 2011
RiceRBP: a database of experimentally identified RNA-binding proteins in Oryza sativa LRobert T Morris, Kelly A Doroshenk, Andrew J Crofts, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?Gunjal Garg, Jay P Shah, Eugene P Toy, et al.
Obstetrics and Gynecology|November 4, 2008
Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcomaJay P Shah, Christopher S Bryant, Sanjeev Kumar, et al.
Gynecologic Oncology|August 23, 2011
Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysisAgnieszka Vay, Sanjeev Kumar, Shelly Seward, et al.
Gynecologic Oncology|January 14, 2018
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic targetGhassan M Saed, Nicole M Fletcher, Michael P Diamond, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2010
Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based studyGunjal Garg, Jay P Shah, J Rebecca Liu, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Reproductive Sciences (Thousand Oaks, Calif.)|August 20, 2020
Molecular Basis Supporting the Association of Talcum Powder Use with Increased Risk of Ovarian CancerNicole M Fletcher, Amy K Harper, Ira Memaj, et al.
Nucleic Acids Research|July 24, 2014
dREAM co-operates with insulator-binding proteins and regulates expression at divergently paired genesMichael Korenjak, Eunjeong Kwon, Robert T Morris, et al.
Journal of Ovarian Research|November 26, 2008
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaBLeigh A Solomon, Shadan Ali, Sanjeev Banerjee, et al.
American Journal of Obstetrics and Gynecology|December 27, 2008
A comparison of younger vs older women with vulvar cancer in the United StatesSanjeev Kumar, Jay P Shah, Christopher S Bryant, et al.
Plant Science : an International Journal of Experimental Plant Biology|March 23, 2011
RiceRBP: a database of experimentally identified RNA-binding proteins in Oryza sativa LRobert T Morris, Kelly A Doroshenk, Andrew J Crofts, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 18, 2011
Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?Gunjal Garg, Jay P Shah, Eugene P Toy, et al.
Obstetrics and Gynecology|November 4, 2008
Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcomaJay P Shah, Christopher S Bryant, Sanjeev Kumar, et al.
Gynecologic Oncology|August 23, 2011
Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysisAgnieszka Vay, Sanjeev Kumar, Shelly Seward, et al.
Gynecologic Oncology|January 14, 2018
Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic targetGhassan M Saed, Nicole M Fletcher, Michael P Diamond, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 14, 2010
Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based studyGunjal Garg, Jay P Shah, J Rebecca Liu, et al.
Pageof 11